← The Wire
DCTHNasdaq
DELCATH SYSTEMS, INC.
Surgical & Medical Instruments & Apparatus · DE · CIK 872912
Treats cancers primary or metastatic to the liver using drug/device combinations
red 8-K · 90d
$405M
Market cap
$12.95
Last close
+0.1%
1D
+12.5%
5D
641K
Volume
Price · last 39 sessions+17.5%
May 4L $10.33 · H $12.95Jun 29
466
Total filings
May 14, 2026
Last filing
12/31
Fiscal year end
8-KExecutive Change · Shareholder VoteMay 14, 202610-Q10-QMay 7, 20268-KResults of OperationsMay 7, 2026DEFA14ADEFA14AApr 2, 2026DEF 14ADEF 14AApr 2, 20268-KCompany UpdateMar 3, 202610-K10-KFeb 26, 20268-KResults of OperationsFeb 26, 2026SC 13D/ASC 13D/AFeb 10, 20268-KResults of Operations · Reg FD DisclosureJan 12, 20268-KCompany UpdateNov 20, 202510-Q10-QNov 4, 20258-KResults of OperationsNov 4, 20258-KResults of Operations · Reg FD DisclosureOct 20, 20258-KBylaw AmendmentAug 15, 202510-Q10-QAug 6, 20258-KResults of OperationsAug 6, 20258-KReg FD Disclosure · Company UpdateMay 22, 20258-KExecutive Change · Shareholder VoteMay 16, 202510-Q10-QMay 8, 20258-KResults of OperationsMay 8, 2025DEFA14ADEFA14AApr 1, 2025DEF 14ADEF 14AApr 1, 20258-KAuditor ChangeMar 21, 202510-K10-KMar 6, 20258-KResults of OperationsMar 6, 20258-KResults of Operations · Reg FD DisclosureJan 13, 20258-KReg FD Disclosure · Company UpdateDec 30, 202410-Q10-QNov 8, 20248-KResults of OperationsNov 8, 20248-KResults of Operations · Company UpdateOct 17, 20248-KReg FD DisclosureAug 29, 20248-KCompany UpdateAug 28, 202410-Q10-QAug 5, 20248-KResults of OperationsAug 5, 20248-KExecutive ChangeJul 19, 20248-KDelisting NoticeJul 9, 20248-KDelisting Notice · Executive ChangeMay 29, 202410-Q10-QMay 14, 20248-KResults of OperationsMay 14, 20248-KMaterial AgreementApr 26, 2024DEFA14ADEFA14AApr 12, 2024DEF 14ADEF 14AApr 12, 202410-K10-KMar 26, 20248-KResults of OperationsMar 26, 20248-KMaterial Agreement · Equity IssuanceMar 19, 20248-KExecutive Change · Reg FD DisclosureMar 19, 20248-KExecutive ChangeFeb 14, 20248-KCompany UpdateJan 31, 2024SC 13GSC 13GJan 9, 20248-KReg FD DisclosureJan 8, 202410-Q9.30.2023 10-QNov 13, 20238-KResults of OperationsNov 13, 20238-KReg FD DisclosureSep 6, 2023SC 13GSC 13GAug 16, 20238-KReg FD Disclosure · Company UpdateAug 15, 202310-Q6.30.2023 10-QAug 9, 20238-KResults of OperationsAug 9, 20238-KReg FD DisclosureAug 4, 2023SC 13GSC 13GJun 26, 2023SC 13GSCHEDULE 13GJun 22, 2023SC 13GSCHEDULE 13GJun 22, 20238-KCompany UpdateJun 22, 20238-KExecutive Change · Bylaw AmendmentJun 13, 20238-KExecutive Change · Reg FD DisclosureJun 7, 202310-Q10-QMay 22, 20238-KResults of OperationsMay 12, 2023DEFA14ADEFA14AMay 1, 2023DEF 14ADEF 14AMay 1, 20238-KMaterial Agreement · Equity IssuanceMar 30, 20238-KReg FD DisclosureMar 28, 20238-KResults of OperationsMar 27, 202310-K10-KMar 27, 2023424B5424B5Feb 27, 20238-KCompany UpdateFeb 24, 20238-KCompany UpdateFeb 14, 20238-KCompany UpdateJan 23, 20238-KCompany UpdateJan 10, 20238-KReg FD DisclosureJan 3, 20238-KMaterial Agreement · Equity IssuanceDec 13, 2022
Insider Activity
◆ Cluster Buy · 2 insidersIn the 90 days to Mar 6, 2026: 2 insiders bought $150K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 6, 2026 | Pennell SandraChief Financial Officer | Buy | 5,533 | $9.04 | $50K |
| Mar 2, 2026 | Michel Gerard JCHIEF EXECUTIVE OFFICER | Buy | 11,200 | $8.96 | $100K |
| Nov 21, 2025 | Sylvester John RichardDirector | Buy | 4,386 | $8.89 | $39K |
| Nov 11, 2025 | Michel Gerard JCHIEF EXECUTIVE OFFICER | Buy | 11,500 | $8.53 | $98K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance